Effectiveness and Safety of Anlotinib With or Without S-1 in the Treatment of Patients With Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. Radiol Oncol 2023, 57 (3), 405-410.